Skip to Main Content

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Securities Fraud Class Action

View Complaint
CompanySpectrum Pharmaceuticals, Inc.
CourtUnited States District Court for the Southern District of New York
Case Number1:22-cv-10292
JudgeHonorable Valerie E. Caproni
Class PeriodMarch 17, 2022 through September 22, 2022
Security TypeCommon Stock

Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Spectrum Pharmaceuticals, Inc. ("Spectrum") (NASDAQ: SPPI) securities between March 17, 2022 and September 22, 2022, inclusive (the “Class Period”). 

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects.  Specifically, Defendants misrepresented and/or failed to disclose that: (1)  the PINNACLE Study, which was a Phase 3 confirmatory trial of a 16 mg dose of Spectrum’s anti-cancer drug pozi QD, was enrolling patients and was on track to be substantially enrolled by November 24, 2022 despite no patients having been enrolled; (2) that the FDA had concerns about inadequate dose optimization data, efficacy and safety data, and did not agree with the design of the PINNACLE study; (3) the status of the PINNACLE study differed greatly than what was told to investors; and (4) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you are a member of the class described above, you may no later than September 24, 2025, move the Court to serve as lead plaintiff of the class, if you so choose. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the purported class may move the Court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

What is a Lead Plaintiff?

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case.  Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

Complete this form with your transactions in Spectrum Pharmaceuticals, Inc. common stock between March 17, 2022, and September 22, 2022.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Spectrum Pharmaceuticals, Inc. prior to the Class Period?
Are you a current or former employee of Spectrum Pharmaceuticals, Inc. ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email